Parallel Trade and the Pricing of Pharmaceutical Products - PowerPoint PPT Presentation

About This Presentation
Title:

Parallel Trade and the Pricing of Pharmaceutical Products

Description:

Parallel Trade and the Pricing of Pharmaceutical Products Conference on Health Economics and the Pharmaceutical Industry Frank M ller-Langer – PowerPoint PPT presentation

Number of Views:128
Avg rating:3.0/5.0
Slides: 38
Provided by: NellSc
Category:

less

Transcript and Presenter's Notes

Title: Parallel Trade and the Pricing of Pharmaceutical Products


1
Parallel Trade and the Pricing of Pharmaceutical
Products
Conference on Health Economics and the
Pharmaceutical Industry
  • Frank Müller-Langer

2
Agenda
  • 1 Introduction
  • 2 Prior literature
  • Double marginalization model with complete
    information
  • Conclusion and ideas for further research

3
Parallel imports (PIs)
  • When do parallel imports actually occur?
  • Why should we care about parallel imports?
  • - Advocates of strong patent rights for new
    pharmaceutical products support a global regime
    of banning parallel imports
  • - Restraints on parallel imports vary widely
    between developed and developing countries and
    even amongst developed countries

4
Questions to be analyzed
  • Why may parallel imports actually occur in
    equilibrium when information is complete?
  • Are parallel imports beneficial or detrimental to
    the producer of a patented product?

5
Agenda
  • 1 Introduction
  • 2 Prior literature Determinants of parallel
    trade
  • Double marginalization model with complete
    information
  • Conclusion and ideas for further research

6
Determinants of Parallel Trade
  • First strand of literature
  • Exclusive distribution rights in foreign
    markets, vertical price control and parallel
    trade Maskus and Chen (2002, 2004)

7
Determinants of Parallel Trade
  • Second strand of literature
  • Price regulations by national governments and
    parallel trade Ganslandt and Maskus (2004),
    Jelovac and Bordoy (2005)

8
Agenda
  • 1 Introduction
  • 2 Prior literature
  • Double marginalization model with complete
    information
  • Conclusion and ideas for further research

9
Double Marginalization Game Assumptions
  • Player 1 Monopolistic manufacturer of
    pharmaceuticals in country A
  • Manufacturer has marginal costs of zero
  • Player 2 Exclusive distributor in country B
  • Players payoff functions their profits
  • Demand in country A
  • Demand in country B
  • Parallel imports are allowed (perfect substitute)
  • Distributor marginal costs of parallel trade,

10
Structure of the game
  • First stage manufacturer chooses the wholesale
    price at which he sells the pharmaceutical
    product to the distributor in country B,
  • Second stage distributor chooses the retail
    price in country B, pB
  • Third stage manufacturer and distributor
    simultaneously choose the prices at which they
    sell the product in country A in a Bertrand price
    competition, and .

11
Bertrand price competition
  • Rules of the game
  • The low-price firm serves the entire market
  • The high-price firm sells nothing
  • Manufacturer has marginal costs of zero
  • Distributor has positive marginal costs of
  • Manufacturer sets a price that is smaller than
    the marginal costs of the distributor,

12
Bertrand price competition
Result PIs will never occur in any sub-game
perfect Nash equilibrium in the double
marginalization game with complete information
13
Distributors decision
  • In the second stage, the distributor anticipates
    that he will be driven out of the market in
    country A in the third stage
  • In the second stage, the distributor sets a
    retail price in country B that is 50 per cent
    higher than the wholesale price set by the
    manufacturer

14
Maximization problem of the manufacturer
15
Solution 1 for low trade costs and high
  • We use the Kuhn-Tucker Theorem and obtain two
    solutions
  • Solution 1
  • Solution 1 only satisfies the non-negativity
    restrictions
  • if

16
Solution 2 for
  • equal to the monopoly price in the double
    marginalization game when parallel imports are
    prohibited
  • equal to the profit-maximizing wholesale price in
    the double marginalization game when parallel
    imports are prohibited

17
Equilibrium Quantities and Prices
PIs allowed PIs prohibited
Price in A
Quantity in A
Wholesale Price in B
Retail Pr. in B
Quantity in B
18
Profit of the manufacturer
  • Parallel imports are allowed
  • 2. Parallel imports are prohibited

19
Net effect on profit when PIs are allowed
  • and
  • and as b gt0.

20
Net effect on profit when PIs are allowed
  • For we obtain
  • Hence,
  • Result Manufacturer generates a lower profit
    when parallel imports are allowed

21
Results of the welfare analysis
  • The net effect of parallel trade on global
    welfare is positive if the market in country A is
    large
  • ( )
  • The net effect of parallel trade on global
    welfare can be negative if trade costs are at an
    intermediate level and countries are virtually
    homogenous in terms of market size ( )

22
Summary of the main results
  • PIs will never occur in a double marginalization
    game with complete information
  • If , potential competition
    from parallel trade does not arise. The
    manufacturer charges the monopoly price in
    country A and the optimal wholesale price in
    country B
  • If , potential competition from
    parallel trade arises. The manufacturer
    strategically sets the wholesale price in country
    B and the price in country A, in order to prevent
    that parallel trade occurs

23
Summary of the main results
  • The manufacturer generates a lower profit when
    parallel imports are allowed as he has to set
    prices strategically in order to deter parallel
    imports

24
Agenda
  • 1 Introduction
  • 2 Prior literature
  • Double marginalization model with complete
    information
  • Ideas for further research

25
Ideas for further research
  • Does parallel trade occur when country A is less
    attractive in terms of market size,
    , and trade costs are very low
  • ?
  • Impact of a price cap in country B?

26
Ideas for further research
  • Parallel trade and medicines for neglected
    infectious and tropical diseases
  • - 99 per cent of global demand for medicines
    for such diseases is generated in the developing
    world
  • - Country A high-income country
  • - Country B low-income country

27
  • Thank you

28
Follow-up paper New timing of the game
  • Stage 0 Manufacturer chooses retail price in
    country A
  • Stage 1 Manufactuer chooses wholesale price in
    country B
  • Stage 2 Distributor chooses retail price in
    country B
  • Stage 3 If , a third firm will
    enter the market, buys the product from the
    distributor in country B and then re-sells the
    product in country A

29
Game with asymmetric information
  • First stage Manufacturer chooses the price at
    which he charges the distributor in country B
  • Second stage Nature chooses the demand in
    country A and country B
  • Third stage Distributor chooses the price he
    charges his customers in country B
  • Fourth stage Manufacturer and distributor play a
    Bertrand game

30
Hypothesis
  • Depending on Natures choices with regard to
    local demand functions parallel imports may occur
    in equilibrium

31
Social welfare analysis of parallel imports
  • Infectious diseases kill 14 million people around
    the world every year, with 90 per cent of those
    deaths occurring in the developing world
  • Furthermore, almost 1,400 new medicines have been
    developed in the last 25 years, but only 1 per
    cent of these were medicines for parasitic and
    infectious tropical diseases that are rampant in
    the developing world

32
Hypothesis
  • Hypothesis There is an important rationale for
    restricting parallel importation of medicines for
    parasitic and infectious tropical diseases that
    are rampant in middle income and low income
    countries
  • Parallel imports would further reduce the
    incentives to invest in RD for medicines for
    parasitic and infectious tropical diseases

33
Parallel Imports and the WTO
  • WTO members are free to choose whether to allow
    or prohibit parallel imports
  • Article 6 of the TRIPS Agreement
  • For the purposes of dispute settlement under
    this Agreement, subject to the provisions of
    Articles 3 and 4, nothing in this Agreement shall
    be used to address the issue of the exhaustion of
    intellectual property rights.

34
Distributors decision
  • In the second stage, the distributor anticipates
    that he will be driven out of the market in
    country A in the third stage
  • Parallel trade does not occur
  • Total profit is equal to the profit generated in
    country B through exclusive distribution

35
Distributors decision
  • The distributor has to pay the wholesale price
  • Maximizes profit according to

36
Distributors decision
  • The first-order condition is given by

37
Parallel trade can have a negative effect on
global welfare , and
Write a Comment
User Comments (0)
About PowerShow.com